AstraZeneca gets a shot on Wall Street
This report is from this week’s CNBC’s UK Exchange newsletter. Like what you see? You can subscribe here. The dispatch There…
Tag: AstraZeneca
AstraZeneca pauses £200m Cambridge investment
AstraZeneca has paused plans to invest £200m at a Cambridge research site in a fresh blow to the UK pharmaceutical…
Stock Movers: AstraZeneca, Philips, Stellantis (Podcast)
Source: Bloomberg, 4:00 www.bloomberg.com #Stock #Movers #AstraZeneca #Philips #Stellantis #Podcast
AstraZeneca Profit, Revenue Lifted by Cancer Drugs
AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines. www.bloomberg.com…
AstraZeneca announces $50bn US investment plans by 2030
AstraZeneca has announced $50bn investment plans in the US by 2030 for drug manufacturing, and research and development (R&D). The…
AstraZeneca to build new Virginia plant as it re-hashes other U.S. investment plans
AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a…
AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh
The office building of international biopharmaceutical company AstraZeneca. Cfoto | Future Publishing | Getty Images AstraZeneca on Monday said it…
AstraZeneca shares show signs of life after successful trials of hypertension drug
Baxdostat trials showed immense promise for huge available market. www.marketwatch.com #AstraZeneca #shares #show #signs #life #successful #trials #hypertension #drug
Stock Movers: Hermes, AstraZeneca, Brenntag (Podcast)
Source: Bloomberg, 3:51 www.bloomberg.com #Stock #Movers #Hermes #AstraZeneca #Brenntag #Podcast
Investors fret on talk of AstraZeneca US move
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…